Atlas Trials

Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

Clinical trial NCT01251575 · COMPLETED

Trial details

NCT number
NCT01251575
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adult Acute Lymphoblastic LeukemiaAdult Acute Myeloid LeukemiaAdult Diffuse Large B-Cell LymphomaAdult Myelodysplastic SyndromeAdult Non-Hodgkin LymphomaAggressive Non-Hodgkin LymphomaChildhood Acute Lymphoblastic LeukemiaChildhood Acute Myeloid LeukemiaChildhood Diffuse Large B-Cell LymphomaChildhood Myelodysplastic SyndromeChildhood Non-Hodgkin LymphomaChronic Lymphocytic Leukemia
Start date
2010-12-01
Primary completion
2018-11-23
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.